Anavex Life Sciences Corp (AVXL)

[wildcard235]

NTRP spun off its assets to Neurotrope Bioscience (NBI) traded on OTC.

If I understand correctly, as of last December, they exist as Synaptogenix, Inc. (SNPX), although I don't know how that transition occurred. They just did a reverse split and (re)uplisted to NASDAQ, and it has mostly the same corporate leaders as it's had for years.

Their main drug candidate, Bryostatin-1, was originally investigated as an anti-cancer agent, then as an anti-HIV agent, and then against many CNS diseases.

Recent progress in their trials appears to be extremely slow.